Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Interaction of herbal products with prescribed medications: A systematic review and meta-analysis.

Awortwe C, Bruckmueller H, Cascorbi I.

Pharmacol Res. 2019 Mar;141:397-408. doi: 10.1016/j.phrs.2019.01.028. Epub 2019 Jan 17.

PMID:
30660822
2.

Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.

Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.

J Pharm Pharmacol. 2019 Jan;71(1):129-138. doi: 10.1111/jphp.12858. Epub 2018 Feb 7. Review.

PMID:
29411879
3.

Clinical risks of St John's Wort (Hypericum perforatum) co-administration.

Soleymani S, Bahramsoltani R, Rahimi R, Abdollahi M.

Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1047-1062. doi: 10.1080/17425255.2017.1378342. Epub 2017 Sep 13. Review.

PMID:
28885074
4.

Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John's Wort?

Mouly S, Lloret-Linares C, Sellier PO, Sene D, Bergmann JF.

Pharmacol Res. 2017 Apr;118:82-92. doi: 10.1016/j.phrs.2016.09.038. Epub 2016 Sep 28. Review.

PMID:
27693910
5.

Celery root extract as an inducer of mania induction in a patient on venlafaxine and St John's Wort.

Khalid Z, Osuagwu FC, Shah B, Roy N, Dillon JE, Bradley R.

Postgrad Med. 2016 Sep;128(7):682-3. doi: 10.1080/00325481.2016.1218263. Epub 2016 Aug 5.

PMID:
27467225
6.

Co-administration of St. John's wort and hormonal contraceptives: a systematic review.

Berry-Bibee EN, Kim MJ, Tepper NK, Riley HE, Curtis KM.

Contraception. 2016 Dec;94(6):668-677. doi: 10.1016/j.contraception.2016.07.010. Epub 2016 Jul 18. Review.

PMID:
27444983
7.

Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.

Fasinu PS, Gurley BJ, Walker LA.

Curr Drug Metab. 2015;17(1):52-64. Review.

PMID:
26526838
8.

Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.

Sprouse AA, van Breemen RB.

Drug Metab Dispos. 2016 Feb;44(2):162-71. doi: 10.1124/dmd.115.066902. Epub 2015 Oct 5. Review.

9.

The effect of induction of CYP3A4 by St John's wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotype.

Markert C, Kastner IM, Hellwig R, Kalafut P, Schweizer Y, Hoffmann MM, Burhenne J, Weiss J, Mikus G, Haefeli WE.

Basic Clin Pharmacol Toxicol. 2015 May;116(5):423-8. doi: 10.1111/bcpt.12332. Epub 2014 Nov 8.

10.

Use of St. John's Wort in potentially dangerous combinations.

Davis SA, Feldman SR, Taylor SL.

J Altern Complement Med. 2014 Jul;20(7):578-9. doi: 10.1089/acm.2013.0216. Epub 2014 Jun 23.

PMID:
24956073
11.

Interaction between different extracts of Hypericum perforatum L. from Serbia and pentobarbital, diazepam and paracetamol.

Rašković A, Cvejić J, Stilinović N, Goločorbin-Kon S, Vukmirović S, Mimica-Dukić N, Mikov M.

Molecules. 2014 Mar 28;19(4):3869-82. doi: 10.3390/molecules19043869.

12.

[Phytotherapy threats with emphasis on St. John's wort medicines].

Sienkiewicz J, Czarnik-Matusewicz H, Wiela-Hojeńska A.

Pol Merkur Lekarski. 2013 Nov;35(209):309-12. Review. Polish.

PMID:
24575655
13.

Influence of St. John's wort on the steady-state pharmacokinetics and metabolism of bosentan.

Markert C, Ngui P, Hellwig R, Wirsching T, Kastner IM, Riedel KD, Burhenne J, Weiss J, Mikus G, Haefeli WE.

Int J Clin Pharmacol Ther. 2014 Apr;52(4):328-36. doi: 10.5414/CP202048.

PMID:
24472406
14.

Drug interactions with phytotherapeutics in oncology.

Haefeli WE, Carls A.

Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):359-77. doi: 10.1517/17425255.2014.873786. Epub 2014 Jan 6. Review.

PMID:
24387348
15.

The effect of St John's wort on the pharmacokinetics of docetaxel.

Goey AK, Meijerman I, Rosing H, Marchetti S, Mergui-Roelvink M, Keessen M, Burgers JA, Beijnen JH, Schellens JH.

Clin Pharmacokinet. 2014 Jan;53(1):103-10. doi: 10.1007/s40262-013-0102-5.

PMID:
24068654
16.

Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.

Russo E, Scicchitano F, Whalley BJ, Mazzitello C, Ciriaco M, Esposito S, Patanè M, Upton R, Pugliese M, Chimirri S, Mammì M, Palleria C, De Sarro G.

Phytother Res. 2014 May;28(5):643-55. doi: 10.1002/ptr.5050. Epub 2013 Jul 30. Review.

PMID:
23897801
17.

St. John's wort for the treatment of psychiatric disorders.

Sarris J.

Psychiatr Clin North Am. 2013 Mar;36(1):65-72. doi: 10.1016/j.psc.2013.01.004. Review.

PMID:
23538077
18.

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I.

Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Review.

PMID:
23394826
19.

An update on the ability of St. John's wort to affect the metabolism of other drugs.

Rahimi R, Abdollahi M.

Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):691-708. doi: 10.1517/17425255.2012.680886. Review.

PMID:
22606944
20.

Pharmacokinetics and cardiovascular effect of etoricoxib in the absence or presence of St. John's Wort in rats.

Radwan MA, Baky NA, Zaghloul I, Aboul-Enein HY.

Arzneimittelforschung. 2012 Jul;62(7):313-8. doi: 10.1055/s-0032-1309043. Epub 2012 Apr 27. Erratum in: Drug Res (Stuttg). 2017 Feb;67(2):131.

PMID:
22549240

Supplemental Content

Loading ...
Support Center